Clinical trial
Phase II Study of Weekly Vinorelbine and Paclitaxel in Elderly Patients With Advanced Non-Small Cell Lung Cancer
NCT00602797 is registered in ClinicalTrials.gov with University of Nebraska as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Study of Weekly Vinorelbine and Paclitaxel in Elderly Patients With Advanced Non-Small Cell Lung Cancer
- Lead sponsor
- University of Nebraska
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 17, 2007
- Completion date
- August 1, 2014
- Enrollment
- 20 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
recurrent non-small cell lung carcinoma, stage iv non-small cell lung cancer